23.4 MONOCLONAL ANTIBODIES
Pharmacology
These are artificially laboratory-produced molecules that enhance the immune system’s ability to fight against pathogens. Monoclonal antibodies target specific antigens, making them effective for treating cancer, autoimmune disorders, and infectious diseases.
23.4.2 ADVANTAGES OF MONOCLONAL ANTIBODIES
Monoclonal antibodies are integral to personalized medicine, enabling tailored treatment approaches based on individual patient profiles. Continued innovation in these antibodies in design and production is critical to improve its effectiveness of therapies, ensuring they are better suited to each patient’s unique biology.
Monoclonal antibodies have significant advantages as;
- i.As compared to traditional drugs, they offer lower toxicity, potential for long-lasting effects.
- ii.These have least side effects as compared to conventional chemotherapeutics.
- iii.These have high specificity, binding to a single target with minimal variability.
- iv.They provide targeted therapy in cancer, reducing damage to healthy tissues.
- v.These are easily to prepare and used for research purpose.
- vi.They reduced the risk of drug interactions.
These technologies enable the simultaneous testing of thousands of potential antibodies, reducing development timelines and enabling faster responses to urgent health challenges like infectious diseases and cancer.